ARCHIVES

FEBT, For Pain Control, Shows Positive Results In Phase III

This article is from The Cancer Letter archive.

Vol. 29 No. 5 | May 26, 2006

Download PDF Visit The Full Archive

Related Articles

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

Group Chairs Seek Role Running NCTN

September 12, 2014